Increased lipid peroxidation in children with autoimmune diseases

Acta Paediatrica, International Journal of Paediatrics

Volumn 86, Issue 6, 1997, Pages 609-612

  Michel, P ^a   Eggert, W ^a   Albrecht Nebe, H ^a   Grune, T ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

4 hydroxynonenal; Childhood; Focal type of scleroderma; Malondialdehyde; Systemic lupus erythematosus

Indexed keywords

4 HYDROXYNONENAL;

ARTICLE; AUTOIMMUNITY; CELL DAMAGE; CHILD; CYSTIC FIBROSIS; DRUG BLOOD LEVEL; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030797243     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1997.tb08943.x     Document Type: Article

References (17)

1. Flitter WD. Free radicals and myocardial reperfusion injury. Br Med Bull 1993; 49: 545-55
2. Supnet MC, Remedios David-CU, Walther FJ. Plasma xanthin oxidase activity and lipid hydroperoxide levels in preterm infants. Pediatr Res 1994; 36: 283-7
3. Brown RK, Kelly FJ. Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr Res 1994; 36: 487-93
4. Nakamura T, Toyomizu M, Nagamoto T. Identification of hydroxyl and hydroperoxyl carbonyls in autooxidized triglyceride. Bull Japan Soc Sci Fish 1982; 48: 1357-62
5. Kwon TW, Watts BM. Malondialdehyde in aqueous solution and its role as a measure of lipid oxidation in foods. J Food Sci 1964; 29: 294-302
6. Rowley D, Gutteridge JMC, Blake D, Farr M, Halliwell B. Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients. Clin Sci 1984; 66: 691-5
7. Greenwald RA. Oxygen radicals, inflammation and arthritis: Pathophysiological considerations and implications for treatment. Semin Arthr Rheum 1991; 20: 219-40
8. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 1982; 25: 1271-7
9. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI; a disease activity index for lupus patients. Arthr Rheum 1992; 35: 630-40
10. Esterbauer H, Schauer RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Rad Biol Med 1991; 11: 81-128
11. Wong SHJ, Knight JA, Hopfer S, Zaharia O, Leach CN, Sunderman FW. Lipoperoxides in plasma measured by liquid chromatographic separation of malondialdehyde-thioharbituric acid adduct. Clin Chem 1987; 33: 214-20
12. Suryaprbha P, Das UN, Ramesh G, Kumar V, Kumar G. Reactive oxygen species, lipid peroxides and essential fatty acids in patients with rheumatoid arthritis and systemic lupud erythematosus. Prostag Leukotr Ess FA 1991; 43: 251-5
13. Wolff SP. Diabetes mellitus and free radicals. Br Med Bull 1993; 49: 642-52
14. Lebranchu Y, Malvy D, Richard MJ, Arnaud J, Favier A, Bardos P. Kawasaki disease and oxidative metabolism. Clin Chim Acta 1990; 187: 193-8
15. Jiang X, Chen F. The effect of lipid peroxides and superoxide dismutase on SLE: A preliminary study. Clin Immun Immunopathol 1992; 63: 39-44
16. Amara A, Constans J, Changier C, Sebban A, Dubourg L, Peuchant E, Pellegrin JL, Leng B, Conri C, Geffards M. Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides. Clin Exp Immun 1995; 101: 233-8
17. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity ol six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthr Rheum 1989; 32: 1107-8